Biotech
AI
Markets
Eli Lilly’s $2.75 Billion Insilico Deal Marks Enterprise AI’s Shift From Hype to Production
Big Pharma's largest generative AI partnership validates vertical specialization over generalist models—and signals that geopolitics won't block deals where ROI is measurable.
Technology
Japan Approves World’s First iPSC Therapies, Reshaping Global Biotech Competition
Commercial authorization for Cuorips and Sumitomo Pharma products validates 20-year development timeline and accelerates regulatory pathways across Asia-Pacific as U.S. and EU lag.
Markets
Moderna Settles $2.25 Billion Patent Dispute, Shares Jump 10% on Legal Clarity
The biotech resolves a long-running lipid nanoparticle infringement case with Arbutus and Genevant, clearing a path for its post-COVID vaccine portfolio.